• Home
• crohn's disease
• Advances in the treatment of Crohn's disease and ulcerative colitis - Mayo Clinic

Advances in the treatment of Crohn's disease and ulcerative colitis - Mayo Clinic

4.8 (791) · $ 20.50 · In stock

When used in a treat-to-target approach, therapies for mucosal healing may favorably modify the natural history of inflammatory bowel disease (IBD), reducing the need for steroids and risk of hospitalization.

AbbVie Announces European Commission Approval of SKYRIZI® (risankizumab) for the Treatment of Moderate to Severe Active Crohn's Disease

PDF) Radiographic evaluation of ulcerative colitis

Guidelines for the management of ulcerative colitis in the adult population (update)

Overview - Mayo Clinic Research

Are Biologics Right for You?

Novel stem cell therapy for perianal fistula in pediatric patients with Crohn's disease - Mayo Clinic

Ulcerative colitis - Wikipedia

Are Biologics Right for You?

Registration for the 2024 Crohn's & Colitis Congress® is now open - American Gastroenterological Association

Crohn's Disease: Mayo Clinic Radio

Inflammatory bowel disease (IBD)